Page last updated: 2024-08-26

imipenem, anhydrous and Cross Infection

imipenem, anhydrous has been researched along with Cross Infection in 366 studies

Research

Studies (366)

TimeframeStudies, this research(%)All Research%
pre-199022 (6.01)18.7374
1990's63 (17.21)18.2507
2000's153 (41.80)29.6817
2010's120 (32.79)24.3611
2020's8 (2.19)2.80

Authors

AuthorsStudies
Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A1
Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A1
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A1
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR1
Grosso, F; Peixe, L; Quinteira, S; Ramos, H1
Bulitta, JB; Drusano, GL; Glauner, AK; Kinzig-Schippers, M; Pfister, W; Sakka, SG; Sörgel, F1
Bonomo, RA; Decker, BK; Hujer, AM; Hujer, KM; Perez, F; Rather, PN1
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y1
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL1
Gianneli, D; Loli, A; Miriagou, V; Tzelepi, E; Tzouvelekis, LS1
Bouallegue, O; Mansour, W; Nordmann, P; Poirel, L1
Chen, TL; Cho, WL; Fung, CP; Shaio, MF; Wu, RC1
Carrillo, B; Esparza-Ahumada, S; Garza-Ramos, U; Hernández, E; Jones, RN; Morfin-Otero, R; Rodriguez-Noriega, E; Sader, HS; Sanchez, A; Silva-Sanchez, J1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC1
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R1
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE1
Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L1
Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY1
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q1
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A1
Bulik, CC; Christensen, H; Nicolau, DP1
Ge, Y; Juan, C; Moya, B; Oliver, A; Pérez, JL; Zamorano, L1
Acosta, J; Beceiro, A; Bou, G; Chaves, F; Merino, M; Poza, M; Sanz, F1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ1
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G1
Chai, Z; Liu, H; Liu, J; Lu, J; Min, Z; Muhammad, M; Yang, Y; Zhang, L1
Ahmadi, A; Shahin, M1
Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L1
Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z1
Bhattacharjee, A; Chakravarty, A; Chanda, DD; Paul, D1
Gholipour, A; Khaledi, M; Shahini Shams Abadi, M; Vafapour, R; Validi, M; Zamanzad, B1
Esmail, MAM; Khairy, RMM; Mahmoud, MS; Shady, RR1
Ebede, SO; Nwafia, IN; Ohanu, ME; Ozumba, UC1
Liu, B; Tong, S1
Gatermann, SG; Körber-Irrgang, B; Korte-Berwanger, M; Kresken, M; Pfennigwerth, N; Seifert, H1
Banerjee, T; Barman, H; Das, A; Kumar, A; Sharma, S; Yadav, G1
Fu, Y; Huang, G; Peng, Y; Tang, C; Yang, Y1
Chang, FY; Huang, LY; Li, JF; Lin, FM; Lin, JC; Siu, LK; Wang, CH; Yang, YS1
Chen, CH; Lin, CH; Lin, JS1
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Amin, M; Dibachi, S; Shahin, M1
Ahmed, MO; Álvarez, R; Daw, MA; Elramalli, AK; Kieffer, N; Nordmann, P; Poirel, L1
Amara, M; Bedos, JP; Breton, N; Cavelot, S; Grimaldi, D; Merrer, J; Nebot, N; Neulier, C; Pangon, B; Tran-Dinh, A; Troché, G; Zuber, B1
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X1
da Silva, LP; da Silveira, M; de Oliveira Emídio, ZP; Fortaleza, CMCB1
Boral, B; Durmaz, R; Ergin, A; Eser, ÖK; Unaldi, Ö1
Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J1
Kaniga, K; Lee, M; Redman, R; Rice, DA1
Chang, HL; Chang, HY; Chang, YF; Chi, CY; Ho, CM; Ho, MW; Lai, CH; Lin, CD; Lin, CW; Lin, HH; Lu, JJ; Teng, LJ; Tien, N; Tseng, SP1
Hsueh, PR; Lee, YT; Tsao, SM1
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D1
Chen, TL; Dou, HY; Fung, CP; Huang, L; Kuo, SC; Lee, MH; Lee, YT; Yu, KW1
Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S1
Cardoso, O; Mendez, IP; Pereira, SG; Reis, T1
Cho, HH; Koo, SH; Kwon, KC; Sung, JY1
Bozkurt, F; Dal, T; Dayan, S; Deveci, Ö; Tekin, A; Tekin, R1
Chen, Z; Liu, P; Liu, S; Pei, D; Xue, X1
Alves, M; Bige, N; Canoui, E; Offenstadt, G; Tankovic, J1
Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H1
Chongsuvivatwong, V; Chusri, S; Doi, Y; McNeil, E; Rivera, JI; Silpapojakul, K; Singkhamanan, K1
Han, J; Jung, JT; Kim, EY; Kim, HG; Kim, TW; Kwon, HH; Kwon, JG; Kwon, JS; Oh, JH1
Canet, P; Cavalcante, Rde S; Fortaleza, CM1
Balík, M; Lipš, M; Siller, M; Strojil, J; Suchánková, H; Urbánek, K1
Cardoso, O; Marques, M; Pereira, J; Pereira, SG1
Egea, P; Fernández-Cuenca, F; Galán-Sánchez, F; Guerrero-Lozano, I; Pascual, Á; Rodríguez-Iglesias, M1
Alcántar-Curiel, MD; Fernández-Vázquez, JL; García-Torres, LF; Gayosso-Vázquez, C; Giono-Cerezo, S; González-Chávez, MI; Jarillo-Quijada, MD; Morfín-Otero, R; Rodríguez-Noriega, E; Santos-Preciado, JI1
Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS1
Eser, F; Güner, HR; Güven, T; Kaya Kalem, A; Taşyaran, MA; Yilmaz, G1
Allou, N; Allyn, J; Augustin, P; Massias, L; Montravers, P; Welsch, C1
Ammari, H; Bakour, S; Olaitan, AO; Rolain, JM; Saoudi, K; Saoudi, S; Touati, A1
Chen, K; Li, M; Li, X; Ma, L; Wang, D; Wu, Z; Zhang, W1
Dong, D; Huang, L; Huang, S; Huang, Y; Li, H; Liu, W; Tong, Y; Wang, X; Wei, X; Yan, X; Yang, Z; Yuan, J; Zhao, X; Zou, D1
He, W; Huang, Y; Li, C; Li, J; Li, Y; Liu, X; Mao, P; Shan, J; Ye, D1
Fujita, T; Kawata, Y; Komatsu, M; Kondo, Y; Kubo, Y; Maehara, K; Migita, S; Murata, R; Nakamura, A; Sugimoto, K; Tanaka, S; Tanimoto, E; Yano, S1
Chang, CJ; Chen, CL; Chiu, CH; Huang, CW; Lee, HY; Wang, YH1
Culebras, E; García-Salguero, C; Picazo, JJ; Rodríguez-Avial, I1
Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ1
Bhadoria, AS; Jindal, A; Kumar, M; Maiwall, R; Sarin, SK1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Chen, TL; Chern, J; Chou, CC; Lai, JH; Liang, SY; Liao, JH; Tsai, SF; Wu, SH; Wu, WL; Yang, JT1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K1
Akalın, H; Heper, Y; İşçimen, R; Kahveci, F; Kelebek, N; Ocakoğlu, G; Özvatan, T; Sınırtaş, M; Yılmaz, E1
Badal, RE; Hackel, MA; Lob, SH; Sahm, DF1
Alnakshabandi, AA; Dlnya, A; Fatah, MH; Ganjo, AR; Goessens, W; Hammerum, AM; Kok, DJ; Kreft, D; Maghdid, DM; Mansoor, IY; Ng, K; Severin, JA; Verbrugh, HA1
Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H1
Damjanova, I; Fenyvesi, H; Jakab, G; Jánvári, L; Kovács, K; Melegh, S; Mestyán, G; Nyul, A; Szabó, H; Tóth, Á1
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M1
Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K1
Culebras, E; López, MC; Picazo, JJ; Ríos, E; Rodríguez-Avial, I1
Bao, CM; Chen, FH; Chen, SM; Cui, EB; Huang, J; Li, T; Liu, X; Ning, NZ; Qu, F; Wang, H; Zhang, JL1
Abdeltwab, NM; El-Domany, RA; El-Magd, MA; Emara, M; Moustafa, WH1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P1
Fang, X; Guo, J; Jin, Y; Liu, C; Pan, F; Qin, L; Yan, W1
Lipš, M; Neely, MN; Strojil, J; Suchánková, H; Urbánek, K1
Baker, S; Duong, HHT; Nga, TVT; Tuan Anh, N; Tuan, HM; Tuan, NS; Vinh Chau, NV; Y, DM1
Avlami, A; Daikos, GL; Giakkoupi, P; Hadjichristodoulou, C; Petrikkos, G; Polemis, M; Tzouvelekis, LS; Vatopoulos, A; Vourli, S; Zappas, S1
Harada, M; Nagasaki, Y; Shimono, N; Takuma, T; Tsuchimochi, N; Uchida, Y1
Chang, SC; Chen, CJ; Tsai, HT; Wang, JT1
Braun J, S; Castillo V, C; García C, P; González R, G; Labarca L, J; Lagos, M; Pérez I, A; Poggi M, H; Porte T, L; Román, JC; Romeo O, E1
Chen, YH; Hsu, HJ; Lee, MF; Peng, CF1
Casuccio, A; Cipolla, D; Corsello, G; Di Carlo, P; Mammina, C; Mazzola, A; Plano, MR; Tantillo, M1
Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P2
Ben Redjeb, S; Mbarek, M; Meddeb, B; Messadi, Aa; Thabet, L; Turki, A1
Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V1
Ariza, J; Dominguez, MA; Gavaldà, L; Gudiol, F; Manzur, A; Peña, C; Pujol, M; Suárez, C; Tubau, F1
Arunpan, P; Jamulitrat, S; Phainuphong, P1
Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV1
Cezário, RC; Costa-Pinto, RM; da Costa Darini, AL; Duarte De Morais, L; Ferreira, JC; Gontijo-Filho, PP1
Heard, M; Lautenbach, E; Marsicano, R; Serrano, S; Stieritz, DD; Tolomeo, P1
Kauermann, G; Kretzschmar, M; Mikolajczyk, RT; Sagel, U1
Balan, G; Lim, KT; Md Yasin, R; Thong, KL; Yeo, CC1
Restrepo, MI1
Amin, A1
Harris, AD; Hsiao, W; Johnson, JK; Lee, MS; Nataro, JP; Smith, G; Stine, OC; Venezia, RA1
Alves, I; Durocher, A; Grailles, G; Minacori, F; Nseir, S; Soury-Lavergne, A1
Catalano, M; Centrón, D; Di Martino, A; Famiglietti, A; Kaufman, S; Merkier, AK; Orman, B; Quiroga, C; Ramírez, MS; Ratier, L; Vay, C1
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C1
Cady, A; Caroff, N; Corvec, S; Lepelletier, D; Lucet, JC; Marraillac, J; Reynaud, A1
Bartoszko-Tyczkowska, A; Gaszyński, W; Tyczkowska-Sieroń, E1
Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M1
Bilker, WB; Kim, M; Lautenbach, E; Schein, J; Synnestvedt, M; Vo, L; Weiner, MG1
Alba, J; Belmonte, O; Drouet, D; Jaffar-Bandjee, MC; Kuli, B; Lugagne-Delpon, N; Moiton, MP; Mourlan, C1
Fugazza, G; Giacobone, E; Landini, P; Migliavacca, R; Navarra, A; Nucleo, E; Pagani, L; Steffanoni, L1
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY1
Piyasirisilp, S; Premprawat, W; Thamlikitkul, V1
Dizbay, M; Hizel, K; Sezer, BE; Tunccan, OG1
Daikos, GL; Douzinas, E; Legakis, NJ; Miriagou, V; Tsakiri, M; Tzelepi, E; Tzouvelekis, LS; Zioga, A1
Culebras, E; Gómez, M; González-Romo, F; Head, J; Morales, G; Picazo, JJ1
Harris, AD; Hsiao, WW; Johnson, JK; Rasko, DA; Stine, OC; Thom, KA1
Chuang, YC; Cooper, CA; Dartois, N; Datsenko, O; Dukart, G; Dzyublik, O; Freire, AT; Gandjini, H; Glumcher, F; Kim, MJ; Korth-Bradley, JM; Maroko, RT; Melnyk, V1
Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D1
Arlet, G; Boutelier, C; Carbonne, A; Castaing, D; Decre, D; Dussaix, E; Gastiaburu, N; Guerin, C; Jarlier, V; Kassis-Chikhani, N; Lavigne-Kriaa, A; Neuville, S; Saliba, F; Samuel, D; Sengelin, C1
Furtado, GH; Gales, AC; Medeiros, EA; Perdiz, LB; Santos, AE; Wey, SB1
Cai, J; Liu, J; Wu, D1
Astagneau, P; Carbonne, A; L'Hériteau, F; Lacavé, L; Miliani, K1
Chung, DR; Ha, YE; Joo, EJ; Kang, CI; Kang, SJ; Lee, NY; Park, SY; Peck, KR; Song, JH1
Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC1
Eagye, KJ; Nicolau, DP1
Huang, ML; Kuo, HY; Lin, MF; Liou, ML; Sung, CH; Tu, CC; Yang, CM; Yeh, HW1
Hong, KW; Jeong, H; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH1
Baron, R; Boles, JM; Bourigault, C; Cosse, M; Daniel, L; Garlantézec, R; Jourdain, S; Le Du, I; Lefevre, M; Lejeune, B; Lelay, G; Prat, G; Renault, A; Tande, D; Tonnelier, JM; Virmaux, M1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN1
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö1
Ajao, AO; Comer, AC; Furuno, JP; Harris, AD; Johnson, JK; McGregor, JC; Moore, AC; Morgan, DJ; Thom, KA1
Doi, M; Kobayashi, K; Koda, S; Kumon, H; Kusano, N; Kuwabara, M; Shimizu, E; Shimizu, W; Sugai, M1
Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK1
Bustamante, Z; Fernández, E; Gallego, L; Rosales, I; Sevillano, E; Umaran, A; Zabalaga, S1
Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK1
Amine, S; Ben Redjeb, S; Boutiba-Ben Boubaker, I; Ghozzi, R; Hammami, S; Saidani, M1
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu1
Chen, CP; Chen, TL; Cho, WL; Fung, CP; Lee, YT; Wang, FD1
Tomoda, H1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G1
Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM1
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN1
Choi, EH; Hong, KB; Kang, DK; Kim, EC; Lee, HJ; Lim, JH; Oh, HS; Park, JD; Son, IS; Song, JS1
Farajnia, S; Higgins, PG; Nahaei, MR; Peymani, A; Seifert, H1
Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G1
Bansal, N; Chander, J; Gupta, V; Singla, N1
Alberti, S; Beceiro, A; Cabot, G; Juan, C; Moyá, B; Oliver, A; Zamorano, L1
Chander, J; Gupta, V; Sidhu, S1
Ozseven, AG; Ozseven, L; Sesli Çetin, E1
Chen, TL; Dou, HY; Fung, CP; Hsueh, PR; Huang, L; Kuo, SC; Lee, MH; Lee, YT; Su, IJ; Yu, KW1
Chang, SC; Dong, SX; Wang, JT1
Liu, CF; Song, WL; Sun, Y; Wang, LJ; Zhang, ZJ1
Cervia, JS1
Choi, EH; Hong, KB; Lee, HJ1
Artiaco, S; Bellomo, F; Bianchi, P; Cicero, G1
Berktaş, M; Ceylan, MR; Cıkman, A; Karahocagil, MK; Parlak, M1
Arpin, C; Bezian, MC; Dubois, V; Gachie, JP; Gavinet, AM; Maire, JP; Menard, F; Quentin, C; Rogues, AM1
Correia, M; Da Silva, GJ; Duarte, A; Leitão, R; Peixe, L; Ribeiro, G; Sousa, JC; Vital, C1
Costa, SF; Levin, AS; Levy, CE; Manrique, AE; Medeiros, EA1
Chen, P; Cheng, WC; Xiang, XD; Zan, JN1
Mikamo, H; Tamaya, T; Yin, XH1
Benomar, S; Bouharrou, A; Habzi, A; Lahbabi, M; Najdi, T; Nejjari, N; Zerhouni, F1
Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC1
Burgmann, H1
Chen, MJ; Wang, H1
Maharwal, S; Sharma, M; Taneja, N1
Cimiotti, J; Della-Latta, P; Gupta, A; Larson, E; Loughrey, M; Rubenstein, D; Saiman, L; Stone, PW1
Abdallah, VO; Brito, DV; Gontijo Filho, PP; Matos, C; Oliveira, EJ1
Alvarez-Lerma, F; Blanco, A; Domínguez-Muñoz, JE; Gener, J; Maraví-Poma, E; Olaechea, P1
Aymon, D; Bally, F; Bille, J; Chiolero, R; Cometta, A; Garbino, J; Glauser, MP; Greub, G; Kinge, T; Krawczyk, L; Lew, D; Romand, JA; Rubinstein, E; Schaller, MD; Stratchounski, L; Zanetti, G1
Benjamin, WH; Chavers, LS; Chavers, P; Funkhouser, E; Moser, SA; Stamm, AM; Waites, KB1
Choi, SH; Chung, JW; Hyong Kim, T; Kim, NJ; Kim, YS; Lee, SO; Ryu, J; Woo, JH1
Hiyama, E; Kodaira, M; Sasaki, M; Sueda, T; Takesue, Y; Yokoyama, T1
Qian, YS; Xiao, GX; Zhuo, C1
Cao, B; Chen, M; Sun, H; Wang, H; Zhu, Y1
Kong, HS; Xu, GY; Xu, XW; Yang, Q; Yu, YS; Zhong, BY1
Bértolo, E; Da Silva, GJ; Duarte, A; Gallego, L; Peixe, L; Quinteira, S; Sousa, JC1
Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A1
Manzar, S1
Cirioni, O; D'Amato, G; Giacometti, A; Kamysz, W; Lukasiak, J; Scalise, G; Silvestri, C; Simona Del Prete, M1
Bernabeu-Wittel, M; García-Curiel, A; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C1
Chong, Y; Ha, GY; Jang, SJ; Kang, JO; Kim, JJ; Lee, K; Shin, BM; Yong, D1
Berry, N; Burnie, JP; Eddleston, J; Hassan, I; Kirby, A; Majumdar, S; Williams, C1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W1
Bal, C; Bauernfeind, A; Ersöz, G; Otağ, F; Salcioğlu, M; Schneider, I1
Dubouix, A; Héritier, C; Marty, N; Nordmann, P; Poirel, L1
Cruz, RP; Goldani, LZ; Zavascki, AP1
Li, DJ; Liu, WL; Sun, ZY; Zhu, XH1
Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kentepozidis, N; Plachouras, D; Tsaganos, T1
Arnal, JM; Berger, P; Franceschini, B; Gainnier, M; Michel, F; Papazian, L; Sainty, JM1
Kollef, MH; Shorr, AF; Susla, GB1
Jackson, WL; Kollef, MH; Ramage, AS; Shorr, AF; Tennenberg, AM; Wu, SC; Zadeikis, N1
Akinci, E; Balaban, N; Bodur, H; Colpan, A; Erbay, A1
Aldabó-Pallás, T; Cayuela, A; Fernández-Hinojosa, E; Garcia-Curiel, A; Garnacho-Montero, J; Jiménez-Jiménez, FJ; Marquez-Vácaro, JA; Ortiz-Leyba, C1
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A1
Bastos, CC; Kokis, VM; Long, JB; Moreira, BM; Pellegrino, FL; Santos, KR; Silva, MG1
Bae, IK; Jeon, BC; Jeong, SH; Kwon, SB; Lee, JH; Lee, K; Lee, SH; Song, JS; Young, D1
d'Escrivan, T; Devos, P; Dubreuil, L; Georges, H; Kipnis, E; Leroy, O1
Beceiro, A; Bou, G; Canle, D; Cartelle, M; Cisneros, JM; del Mar Tomas, M; Llinares, P; Molina, F; Pertega, S; Villanueva, R1
Akcay, MN; Altoparlak, U; Erol, S; Ertek, M; Ozkurt, Z1
Alba, J; Ishii, Y; Kimura, S; Matsushima, Y; Shiroto, K; Watanabe, K; Yamaguchi, K1
Aubron, C; Collet, L; Fortineau, N; Nicolas, P; Nordmann, P; Poirel, L1
Kuti, JL; Nicolau, DP; Sun, HK1
Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Ribera, A; Rodríguez-Baño, J; Vila, J1
Bar, K; Bearman, GM; Edmond, MB; Marra, AR; Wenzel, RP1
Han, K; Hong, SB; Kim, J; Lee, J; Shin, HS; Shin, KS; Son, BR; Youn, SJ1
Manolis, EN; Metzidie, E; Pournaras, S; Sofianou, D; Tsakris, A1
Alvarez-Lerma, F; Castillo, F; Cerdá, E; Insausti, J; Martínez-Pellús, A; Olaechea, P; Palomar, M1
Jin, ZJ; Li, CR; Luo, L; Peng, SH1
Chiu, CH; Chu, C; Lin, JY; Lin, TY; Liu, SY; Su, LH1
Agodi, A; Anzaldi, A; Barchitta, M; Di Popolo, A; Ghiraldi, E; Mattaliano, A; Travali, S; Zarrilli, R1
Cooper, A; Joshi, M; Kassira, W; McCarthy, M; Metzler, M; Olvey, S1
Luczak, M; Pszenna, M; Rokosz, A2
Luczak, M; Marchel, H; Rudnicka, J; Wroblewska, MM1
Biswas, D; Prasad, R; Sarkar, B; Sharma, JP1
Katsifa, H; Kontodimou, A; Polemis, M; Tsorlini, H; Tzouvelekis, LS; Vatopoulos, AC; Vourli, S1
Antachopoulos, C; Benos, A; Katragkou, A; Kotsiou, M; Roilides, E; Sofianou, D; Tamiolaki, M1
Bille, J; Bugnon, D; Cotting, J; Décosterd, L; Giannoni, E; Majcherczyk, P; Moessinger, A; Moreillon, P; Zanetti, G1
Leitner, E; Lode, H; Schmitt, DV; Welte, T1
Bilker, WB; Fishman, NO; Lautenbach, E; Nachamkin, I; Sheridan, A; Weiner, MG1
An, YJ; Bae, IK; Jang, SJ; Jeong, SH; Lee, K; Lee, SH; Park, KO; Sohn, SG; Sung, KH; Yang, KS; Young, D1
Abbassi, MS; Achour, W; Ben Hassen, A; Cherif, A; Jabnoun, S; Khrouf, N1
Bonello, M; Dell'Aquila, R; Loreto, PD; Nalesso, F; Rodighiero, MP; Ronco, C; Spanò, E1
Bornemann, R; Krämer, A; Kretzschmar, M; Mikolajczyk, RT; Sagel, U1
An, HG; Jeon, SS; Kang, IS; Yu, SM1
Bergès, L; Deplano, A; Rodriguez-Villalobos, H; Struelens, MJ1
Fujiue, Y; Gotoh, N; Hayashida, S; Itaha, H; Kadono, M; Kashiyama, S; Kohara, T; Komatsuzawa, H; Kouda, S; Kuwabara, M; Ohara, M; Onodera, M; Sasaki, M; Sugai, M; Usui, T; Yokoyama, T1
Chen, YG; Li, LJ; Yang, Q; Yu, YS; Zhou, H1
Melzer, M; Petersen, I1
Adams, J; de Oliveira Garcia, D; Doi, Y; Ghilardi, AC; Paterson, DL1
Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J1
Doroszkiewicz, W; Kakol, A; Korzekwa, K; Wojnicz, D1
Ng, SY; Poh, K; Tan, TY1
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN1
Akova, M; Altun, B; Gürkan Aydin, N; Hasçelik, G; Metan, G; Zarakolu, P1
Li, LJ; Wei, ZQ; Yang, Q; Yu, YS; Zhou, H1
Barth, AL; Gaspareto, PB; Martins, AF; Zavascki, AP1
Jamulitrat, S; Suwalak, N; Thongpiyapoom, S1
Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A1
Levi, K; Towner, KJ; Vlassiadi, M1
Basustaoglu, A; Eraksoy, H; Korten, V; Kurt, H; Ozturk, R; Ulusoy, S; Yaman, A; Yuce, A; Zarakolu, P1
Grundmann, H; Jonas, D; Meyer, E; Schwab, F1
Fridkin, SK; Hayden, MK; Lolans, K; Mueller, MR; Phillips, L; Quinn, JP; Warren, DK1
Joseph, J; Rodvold, KA1
Ivanov, DV1
Dowzicky, M; Kuti, JL; Nicolau, DP1
Diomidous, M; Ikonomidis, A; Markou, F; Poulou, A; Pournaras, S; Spanakis, N; Tsakris, A; Vrizas, D1
Levin, AS; Moretti, ML; Oliveira, HB; Pereira, GH1
Pranada, F; Pusztai-Markos, Z1
Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH1
Härmä, M; Köljalg, S; Lyytikäinen, O; Vuopio-Varkila, J1
Başustaoğlu, AC; Baysallar, M; Gün, H; Haznedaroğlu, T; Saraçli, MA1
Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Eller, J; Hamacher, J; Lode, H; Schaberg, T1
Lacey, SL; Want, SV1
Harris, SP; Muder, RR; Nguyen, MH; Pasculle, AW1
Brun-Buisson, C; Chemineau, V; De Gatines, G; Duval, J; Legrand, P; Tankovic, J1
Jones, RN; Marshall, SA1
Burns, J; Eisner, W; Go, ES; Kreiswirth, B; Mariano, N; Mosinka-Snipas, K; Rahal, JJ; Urban, C1
Baumgartner, JD; Chopart, P; Cometta, A; Eggimann, P; Herter, C; Huber, O; Lew, D; Pittet, D; Schaad, U; Zimmerli, W1
Reboli, AC; Wood, CA1
Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R1
Spencer, RC1
Finch, RG; Glauser, M; Norrby, SR1
de Champs, C; Gazuy, N; Guelon, D; Henquell, C; Sirot, D; Sirot, J1
Avraham, I; Berger, BJ; Go, E; Mariano, N; Rahal, JJ; Rubin, D; Urban, C1
Babalova, M; Blahová, J; Hupková, M; Krcméry, V; Schäfer, V1
Ayers, LW; Barnishan, J; Fass, RJ1
Bastian, A; Bestehorn, K; Büchele, G; Gaus, W; Laubenthal, HJ; Rodloff, AC1
Baldassarre, R; Comunale, L; Poletti, G; Tallarigo, C1
Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Spanik, S; Trupl, J1
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K1
Archibald, L; Gaynes, R; McGowan, JE; Monnet, D; Phillips, L; Tenover, F1
Carmeli, Y; Samore, MH1
Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS1
Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI1
Garau, J; Martínez Lacasa, J1
Blanquer, J; Cobo, L; Corcia, S; Daguerre, M; de Latorre, FJ; Del Nogal, F; Garau, J; León, C; Net, A; Rello, J1
Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW1
Eltahawy, AT1
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV1
Modakkas, EM; Sanyal, SC1
Blahová, J; Králiková, K; Krcméry, V; Mlynarcík, D; Trupl, J1
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C1
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G1
Allerberger, F; Bauernfeind, A; Dierich, MP; Eberlein, E; Fille, M; Jungwirth, R; Schneider, I; Speer, G1
Rokosz, A; Sawicka-Grzelak, A1
Arbo, MD; Barefoot, L; Hariharan, R; Nathan, C; Snydman, DR; Weinstein, RA1
Igari, J; Nakamura, A; Oguri, T; Tabe, Y1
Caldwell, JW; Johnson, RH; Singh, S1
Carmeli, Y; DeGirolami, P; Samore, MH; Troillet, N; Venkataraman, L1
Iakovlev, SV1
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B1
Zafar, A1
Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F1
Bou, G; Cerveró, G; Domínguez, MA; Martínez-Beltrán, J; Quereda, C2
Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D1
Alvarez-Lerma, F; Bauer, TT; Blanquer, J; Castillo, F; Leal-Noval, SR; León-Gil, C; Martínez-Pellús, A; Nadal, P; Palomar, M; Ros, F; Torres, A1
Decré, D; Deleuze, A; Desmonts, JM; Fierobe, L; Joly-Guillou, ML; Lucet, JC; Mantz, J; Muller-Serieys, C1
Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J1
Bello, H; Cerda, F; Domínguez, M; González, G; Mella, S; Sepúlveda, M; Zemelman, R1
Combest, A; Mariano, N; Rahal, JJ; Segal-Maurer, S; Sorin, M; Urban, C1
Salaria, M1
Amyes, SG; Atay, T; Gülay, Z1
Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG1
Barth, AL; de Freitas, AL1
Benedetto, G; Enrichens, F; Franchello, A; Mao, P; Olivero, G; Olivero, S; Sciascia, C1
De Rose, V; Pozzi, E1
Aresu, G; Ceccio, S; Garau, G; Melis, S; Morini, M; Palomba, A; Pautasso, M; Piu, G1
Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E1
Culver, DH; Gaynes, RP1
Shimada, K1
Aubert, G; Boylot, D; Brunon, J; Dorche, G; Duthel, R; Jacquemond, G; Pozzetto, B1
Bengel, D; Przechera, M; Risler, T1
Hamon-Poupinel, V; Le Coutour, X; Malbruny, B; Vergnaud, M1
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O1
Bercault, N; Demasure, M; Gueveler, C; Martin, P; Poisson, D1
Norrby, SR1
Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS1
Fujita, J; Higuchi, K; Irino, S; Nakano, M; Negayama, K; Yamaji, Y1
Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP1
Duval, J; Soussy, CJ1
Matsumoto, K; Nagatake, T1
Bechrakis, P; Bilalis, D; Giamarellou, H; Mandragos, K; Pigas, K; Sfikakis, P1
Bodey, GP; Elting, LS; Fainstein, V; Khardori, N1
Antal, M; Knothe, H; Krcméry, V; Seginková, Z1
Avril, JL; Bousser, J; Donnio, PY; Hercouet, H1
Kahan, F; Kropp, H1
Delzell, D; Kabins, SA; Nathan, C; Weinstein, RA1
Baratta, E; Bucaneve, G; Del Favero, A; Grignani, F; Menichetti, F; Pasticci, MB; Patoia, L1
Forder, AA; Linton, DM; Plumb, H; Potgieter, PD1
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV1
Citron, DM; Goldstein, EJ1
Roselle, GA1
Bure, AM; Laisne, MJ; Pangon, B; Regnier, B; Rouveix, E; Vachon, F; Wolff, M1
Daikos, GK; Galanakis, N; Giamarellou, H; Sfikakis, P; Voutsinas, D1
Santos-Ferreira, MO; Vital, JO1
Bertch, K; Foster, TS; Rapp, RP; Tibbs, P; Young, B1
Cumberland, NS; Jones, KP1
Bergogne-Bérézin, E; Joly-Guillou, ML1
Forst, H; Lenhart, FP; Ruckdeschel, G; Unertl, K1
Duma, RJ; Gebhart, RL; Groschel, DH; Mandell, GL; Palmer, DL; Salata, RA; Scheld, WM; Wade, BH; Wenzel, RP1
Starr, SE1

Reviews

11 review(s) available for imipenem, anhydrous and Cross Infection

ArticleYear
Global challenge of multidrug-resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans

2007
[Mode of action of microbial anti-MRSA agents].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:1

    Topics: Acetylcysteine; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Cross Infection; Diterpenes; Drug Design; Drug Resistance, Bacterial; Drug Synergism; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mycotoxins; Spiro Compounds

2012
Appropriate use of the carbapenems.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections

2004
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2

    Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic

2005
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome

2008
Changing role of carbapenems in the treatment of lower respiratory tract infections.
    Scandinavian journal of infectious diseases. Supplementum, 1995, Volume: 96

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ceftazidime; Cilastatin; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Respiratory Tract Infections; Thienamycins

1995
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1995, Volume: 47, Issue:3

    Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections

1995
[The role of carbapenems in the treatment of nosocomial infection].
    Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Bacterial; Meropenem; Pneumonia, Bacterial; Skin Diseases, Infectious; Thienamycins

1997
Imipenem.
    Indian pediatrics, 2001, Volume: 38, Issue:12

    Topics: Adolescent; Child; Child, Preschool; Cross Infection; Exanthema; Humans; Imipenem; Infant; Seizures; Thienamycins

2001
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1

    Topics: Acute Disease; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Thienamycins

1991
Antimicrobial therapy of bacterial sepsis in the newborn infant.
    The Journal of pediatrics, 1985, Volume: 106, Issue:6

    Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins

1985

Trials

28 trial(s) available for imipenem, anhydrous and Cross Infection

ArticleYear
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cilastatin; Critical Illness; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Protease Inhibitors; Tandem Mass Spectrometry; Treatment Outcome

2007
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Young Adult

2014
A randomized open label study of 'imipenem vs. cefepime' in spontaneous bacterial peritonitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Imipenem; India; Liver Cirrhosis; Male; Middle Aged; Paracentesis; Peritonitis; Risk Factors; Severity of Illness Index; Survival Analysis; Time Factors

2016
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
    Diagnostic microbiology and infectious disease, 2010, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Double-Blind Method; Drug Combinations; Hospital Mortality; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Pneumonia; Pneumonia, Ventilator-Associated; Tigecycline; Treatment Outcome

2010
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
    Critical care (London, England), 2012, Feb-15, Volume: 16, Issue:1

    Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin

2012
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    Clinical therapeutics, 2003, Volume: 25, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa

2003
Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
    Intensive care medicine, 2003, Volume: 29, Issue:11

    Topics: Aged; Antibiotic Prophylaxis; APACHE; Cause of Death; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Administration Schedule; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Incidence; Infection Control; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Severity of Illness Index; Spain; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2003
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Adult; Aged; APACHE; Cefepime; Cephalosporins; Cilastatin; Critical Care; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Protease Inhibitors; Respiration, Artificial; Thienamycins

2003
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2

    Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Cross Infection; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome; Ventilators, Mechanical

2005
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
    Respiratory medicine, 2006, Volume: 100, Issue:9

    Topics: Anti-Bacterial Agents; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Protease Inhibitors; Tazobactam; Tobramycin; Treatment Outcome

2006
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
    Infection, 2006, Volume: 34, Issue:3

    Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome

2006
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6

    Topics: Adult; Aged; Bacteremia; Bacterial Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritonitis; Pneumonia; Prospective Studies

1994
Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged

1993
[Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1996, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cost-Benefit Analysis; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Protease Inhibitors; Thienamycins; Treatment Outcome

1996
[Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
    Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1995, Volume: 47, Issue:3

    Topics: Adult; Aged; Carbapenems; Chi-Square Distribution; Cilastatin; Cross Infection; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Protease Inhibitors; Thienamycins; Urinary Tract Infections

1995
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
    Archives of surgery (Chicago, Ill. : 1960), 1997, Volume: 132, Issue:10

    Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries

1997
Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins

1997
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
    JAMA, 1998, Oct-14, Volume: 280, Issue:14

    Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1998
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam

1998
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A

    Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Health Care Costs; Humans; Imipenem; Male; Patient Admission; Pneumonia, Bacterial; Prospective Studies; Retrospective Studies; Thienamycins

1999
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
    Thorax, 2000, Volume: 55, Issue:12

    Topics: Adult; Aged; Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Survival Rate; Thienamycins; Treatment Outcome

2000
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
    Critical care medicine, 2002, Volume: 30, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha

2002
Imipenem-cilastatin in the treatment of hospital infections.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1

    Topics: Cilastatin; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Imipenem; Prognosis; Protease Inhibitors; Thienamycins; Treatment Outcome

1991
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies

1991
Challenges in the design of trials to evaluate antibacterial agents in serious infections.
    The Journal of hospital infection, 1990, Volume: 15 Suppl A

    Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Europe; Female; Humans; Imipenem; Male; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Urinary Tract Infections

1990
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
    The Journal of hospital infection, 1990, Volume: 15 Suppl A

    Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis

1990
Pefloxacin versus imipenem in the therapy of nosocomial lung infections of intensive care unit patients.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B

    Topics: Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Cross Infection; Female; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Lung Diseases; Male; Middle Aged; Pefloxacin; Prospective Studies; Pseudomonas Infections; Time Factors

1990

Other Studies

328 other study(ies) available for imipenem, anhydrous and Cross Infection

ArticleYear
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids

2007
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests

2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome

2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests

2007
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome

2007
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic

2007
Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Cross Infection; Humans; Plasmids; Portugal

2007
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA

2007
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain

2007
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Edetic Acid; Greece; Humans; Imipenem; Integrons; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2008
Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Acinetobacter baumannii; Africa; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Polymerase Chain Reaction; Tunisia

2008
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Primers; DNA Transposable Elements; DNA, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Transformation, Genetic

2008
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Mexico; Models, Genetic; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan

2008
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids

2008
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction

2008
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:11

    Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa

2009
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea

2010
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction

2010
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Young Adult

2010
Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections

2010
OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Molecular Epidemiology; Molecular Sequence Data; Plasmids; Recombination, Genetic; Spain; Species Specificity

2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae

2010
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction

2011
Factors behind the prevalence of carbapenem-resistant Klebsiella pneumoniae in pediatric wards.
    Medicine, 2021, Sep-10, Volume: 100, Issue:36

    Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Maternal-Child Health Services; Pregnancy

2021
Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran.
    Annals of clinical microbiology and antimicrobials, 2021, Nov-03, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Inpatients; Iran; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa

2021
Machine learning for identifying resistance features of
    Journal of medical microbiology, 2021, Volume: 70, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines

2021
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors

2023
An insight into analysis and elimination of plasmids encoding metallo-β-lactamases in Pseudomonas aeruginosa.
    Journal of global antimicrobial resistance, 2020, Volume: 21

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cross Infection; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Dodecyl Sulfate; Suppuration; Urine

2020
Phenotypic and genotypic detection of metallo-β-lactamases in A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran.
    BMC research notes, 2019, Sep-18, Volume: 12, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Imipenem; Iran; Meropenem; Metalloproteins; Microbial Sensitivity Tests; Phenotype

2019
Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
    International journal of clinical practice, 2020, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult

2020
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria.
    Annals of clinical microbiology and antimicrobials, 2019, Dec-12, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; Humans; Imipenem; Male; Middle Aged; Nigeria; Risk Factors; Tertiary Care Centers; Young Adult

2019
An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination.
    BMC infectious diseases, 2019, Dec-21, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Bronchoscopes; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Stenotrophomonas maltophilia

2019
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2020
Adaptations of carbapenem resistant
    Journal of medical microbiology, 2021, Volume: 70, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Physiological; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Female; Genes, Bacterial; Humans; Imipenem; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Virulence

2021
Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
    Burns : journal of the International Society for Burn Injuries, 2017, Volume: 43, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Burn Units; Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins; Wound Infection

2017
Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
    American journal of infection control, 2017, Oct-01, Volume: 45, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Attitude of Health Personnel; beta-Lactam Resistance; Caregivers; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Guideline Adherence; Hand Hygiene; Health Knowledge, Attitudes, Practice; Hospitals, General; Humans; Imipenem; Infection Control; Male; Middle Aged; Molecular Typing; Taiwan; Young Adult

2017
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2017, 06-01, Volume: 59

    Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged

2017
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
    Clinical therapeutics, 2017, Volume: 39, Issue:8

    Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult

2017
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2017
Prevalence of class 1 integrons and plasmid-mediated qnr-genes among Enterobacter isolates obtained from hospitalized patients in Ahvaz, Iran.
    Le infezioni in medicina, 2017, Dec-01, Volume: 25, Issue:4

    Topics: Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Fluoroquinolones; Genes, Bacterial; Humans; Imipenem; Integrons; Iran; Meropenem; Microbial Sensitivity Tests; Plasmids; Thienamycins

2017
Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya.
    Journal of global antimicrobial resistance, 2018, Volume: 13

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Health Facilities; Humans; Imipenem; Klebsiella; Libya; Microbial Sensitivity Tests; Multilocus Sequence Typing

2018
Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
    The Journal of hospital infection, 2018, Volume: 100, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Drinking Water; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Porins; Pseudomonas aeruginosa; Pseudomonas Infections

2018
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
    Zhonghua wei zhong bing ji jiu yi xue, 2016, Volume: 28, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins

2016
Weather, climate control, and imipenem-resistance in Acinetobacter baumannii: an ecological approach.
    Infection control and hospital epidemiology, 2018, Volume: 39, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Climate; Cross Infection; Drug Resistance, Bacterial; Hospital Units; Humans; Imipenem; Microbial Sensitivity Tests; Temperature; Weather

2018
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Annals of clinical microbiology and antimicrobials, 2019, Jul-02, Volume: 18, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Phylogeny; Prospective Studies; Turkey

2019
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies

2019
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.
    Surgical infections, 2013, Volume: 14, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Cefepime; Cephalosporins; Chi-Square Distribution; China; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Public Health Surveillance; Retrospective Studies

2013
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cilastatin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Minocycline; Piperacillin; Sulbactam; Tigecycline; Treatment Outcome

2013
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers

2013
Risk factors for imipenem-nonsusceptible Acinetobacter nosocomialis bloodstream infection.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2014, Volume: 47, Issue:4

    Topics: Academic Medical Centers; Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Cross Infection; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors

2014
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9

    Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence

2013
Prevalence and molecular epidemiology of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamases from two central hospitals in Portugal.
    Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Gene Transfer, Horizontal; Hospitals, Urban; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Portugal; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections

2013
Nosocomial infection by sequence type 357 multidrug-resistant Acinetobacter baumannii isolates in a neonatal intensive care unit in Daejeon, Korea.
    Annals of laboratory medicine, 2013, Volume: 33, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction; Republic of Korea

2013
Carbapenem resistance in Acinetobacter baumannii: where is it heading?
    Le infezioni in medicina, 2013, Volume: 21, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Hospitals, University; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Prognosis; Risk Factors; Thienamycins; Turkey

2013
[Analysis of drug resistance and drug resistance genes of imipenem-resistant Pseudomonas aeruginosa strains isolated from burn wards].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2014, Volume: 30, Issue:1

    Topics: Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2014
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
    Medecine et maladies infectieuses, 2014, Volume: 44, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Substrate Specificity

2014
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Mikrobiyoloji bulteni, 2014, Volume: 48, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins

2014
Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Animals; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Moths; Retrospective Studies; Thienamycins; Treatment Outcome

2014
Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years.
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Volume: 63, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cholangitis; Citrobacter freundii; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Time Factors

2014
Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: An appraisal of the effect of colonization pressure.
    Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Burn Units; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Risk Factors

2014
Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult

2015
Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Spain

2015
Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Archives of medical research, 2014, Volume: 45, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biological Transport; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Hydrazones; Imipenem; Meropenem; Mexico; Microbial Sensitivity Tests; Thienamycins

2014
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    American journal of infection control, 2014, Volume: 42, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins

2014
Increasing resistance of nosocomial Acinetobacter baumannii: are we going to be defeated?
    Turkish journal of medical sciences, 2014, Volume: 44, Issue:1

    Topics: Acinetobacter baumannii; Cross Infection; Drug Resistance, Bacterial; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors

2014
Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Creatinine; Cross Infection; Extracorporeal Membrane Oxygenation; Humans; Imipenem; Lung Transplantation; Male; Middle Aged; Respiratory Distress Syndrome; Respiratory Insufficiency; Transplant Recipients

2015
Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Edetic Acid; Female; Gene Expression Regulation, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mutation; Phylogeny; Plasmids; Sequence Alignment; Sequence Analysis, DNA; Transcription Factors

2015
Identification and characteristics of imipenem-resistant Acinetobacter baumannii in surgical wards in a Chinese university hospital.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; China; Colistin; Cross Infection; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Hospital Units; Hospitals, University; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Molecular Typing

2015
A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Kinetics; Meropenem; Molecular Sequence Data; Plasmids; Thienamycins

2015
A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
    BMC infectious diseases, 2015, Apr-11, Volume: 15

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Equipment Contamination; Female; Gloves, Protective; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged

2015
Spread of OXA-23-producing Acinetobacter baumannii ST2 and ST246 in a hospital in Japan.
    Journal of medical microbiology, 2015, Volume: 64, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Japan; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Thienamycins

2015
Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA, Intergenic; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Taiwan

2015
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins

2015
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:5

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins

2017
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2016
Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.
    Molecular & cellular proteomics : MCP, 2016, Volume: 15, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Binding Sites; Cross Infection; Humans; Imipenem; Models, Molecular; Mutation; Phosphoproteins; Phosphorylation; Protein Structure, Tertiary; Proteome; Proteomics; Tandem Mass Spectrometry

2016
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult

2015
Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
    Respirology (Carlton, Vic.), 2016, Volume: 21, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Shock, Septic

2016
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
    Journal of the Pediatric Infectious Diseases Society, 2017, Mar-01, Volume: 6, Issue:1

    Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests

2017
OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Child, Preschool; Clone Cells; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gene Expression Regulation, Bacterial; Humans; Imipenem; Iraq; Male; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence

2016
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Journal of applied microbiology, 2016, Volume: 121, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins

2016
Emergence and interhospital spread of OXA-48-producing Klebsiella pneumoniae ST395 clone in Western Hungary.
    Infectious diseases (London, England), 2017, Volume: 49, Issue:3

    Topics: beta-Lactamases; Cross Infection; Genotype; Hospitals; Humans; Hungary; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Thienamycins

2017
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult

2017
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
    Advances in experimental medicine and biology, 2016, Volume: 952

    Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome

2016
Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
    Journal of medical microbiology, 2017, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carrier State; Cefotaxime; Ceftazidime; Child; Child, Preschool; Cross Infection; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Feces; Female; Gastrointestinal Microbiome; Hospitalization; Humans; Imipenem; Infant; Intestines; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Spain; Thienamycins; Young Adult

2017
Molecular epidemiology of bla
    BMC infectious diseases, 2017, 01-05, Volume: 17, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Follow-Up Studies; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing

2017
Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Humans; Imipenem; Inosine Monophosphate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2017
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections

2017
Hospital-acquired pneumonia due to Achromobacter xylosoxidans in the elderly: A single-center retrospective study in Beijing.
    Journal of infection in developing countries, 2017, Jan-30, Volume: 11, Issue:1

    Topics: Achromobacter denitrificans; Aged; Aged, 80 and over; Anti-Bacterial Agents; Beijing; beta-Lactam Resistance; Catheters, Indwelling; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Male; Pneumonia, Bacterial; Retrospective Studies; Risk Factors

2017
Is continuous infusion of imipenem always the best choice?
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Pneumonia, Bacterial; Staphylococcus aureus; Time Factors

2017
Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
    Journal of medical microbiology, 2017, Volume: 66, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phenotype; Prevalence; Tandem Repeat Sequences; Vietnam; Young Adult

2017
Epidemiology of metalloenzyme-producing Pseudomonas aeruginosa in a tertiary hospital in Greece.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Greece; Humans; Imipenem; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections

2008
Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008, Volume: 14, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Urine

2008
Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Chi-Square Distribution; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Meropenem; Middle Aged; Regression Analysis; Thienamycins

2008
[Presence of metallo beta-lactamases in imipenem-resistant Pseudomonas aeruginosa].
    Revista medica de Chile, 2008, Volume: 136, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genes, Bacterial; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult

2008
Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Hybridization, Genetic; Imipenem; Integrons; Microbial Sensitivity Tests; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Taiwan

2008
Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Acta pharmacologica Sinica, 2008, Volume: 29, Issue:12

    Topics: Anti-Bacterial Agents; Breast Feeding; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Milk, Human; Proportional Hazards Models; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Survival Rate

2008
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
    Journal of Korean medical science, 2008, Volume: 23, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin

2008
[Surveillance of multidrug resistant bacteria in a Tunisian hospital].
    La Tunisie medicale, 2008, Volume: 86, Issue:11

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Burns; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pseudomonas aeruginosa; Retrospective Studies; Sentinel Surveillance; Staphylococcus aureus; Tunisia

2008
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
    Bosnian journal of basic medical sciences, 2009, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin

2009
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
    The Journal of infection, 2009, Volume: 58, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2009
Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2009, Volume: 92, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Confounding Factors, Epidemiologic; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Bed Capacity, 500 and over; Hospital Mortality; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Thailand

2009
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:5

    Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:5

    Topics: beta-Lactamases; Brazil; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:8

    Topics: Anti-Bacterial Agents; Ceftazidime; Colony Count, Microbial; Cross Infection; Cross-Sectional Studies; Delaware; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Long-Term Care; Microbial Sensitivity Tests; New Jersey; Pennsylvania; Prevalence; Proteus mirabilis; Skilled Nursing Facilities

2009
Mixture model to assess the extent of cross-transmission of multidrug-resistant pathogens in hospitals.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Poisson Distribution; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Time Factors

2009
Characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Public; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction

2009
Efficacy of intravenous infusion of doripenem.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated

2009
Clinical and economic consequences of ventilator-associated pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1

    Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index

2009
The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit.
    The Journal of infectious diseases, 2009, Sep-15, Volume: 200, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Causality; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Patient Admission; Pneumonia, Bacterial; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Societies, Medical; Stenotrophomonas maltophilia

2010
Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina.
    Journal of infection in developing countries, 2008, Jun-01, Volume: 2, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Meropenem; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins

2008
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
    Journal of infection in developing countries, 2008, Jun-01, Volume: 2, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela

2008
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Prospective Studies; Pseudomonas aeruginosa; Rectum; Risk Factors

2010
[Influence of antibiotic-therapy on the selection of multi-drug resistant pathogens].
    Medycyna doswiadczalna i mikrobiologia, 2009, Volume: 61, Issue:2

    Topics: Amoxicillin-Potassium Clavulanate Combination; Ceftazidime; Cross Infection; Drug Resistance, Multiple; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus

2009
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
    The new microbiologica, 2009, Volume: 32, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins

2009
Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
    Infection control and hospital epidemiology, 2009, Volume: 30, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Case-Control Studies; Cohort Studies; Costs and Cost Analysis; Cross Infection; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multivariate Analysis; Pennsylvania; Prevalence; Risk Factors

2009
[Evolution of Enterobacteriaceae resistance to antibiotics in Reunion Island: emergence of extended-spectrum beta-lactamases].
    Pathologie-biologie, 2010, Volume: 58, Issue:1

    Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporinase; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Imipenem; Retrospective Studies; Reunion; Substrate Specificity

2010
Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.
    BMC microbiology, 2009, Dec-22, Volume: 9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Cross Infection; Culture Media; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Profiling; Glucose; Humans; Imipenem; Iron; Polysaccharides, Bacterial

2009
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan

2010
Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010, Volume: 93 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cross Infection; Drugs, Generic; Female; Hospitalization; Hospitals, University; Humans; Imipenem; Male; Medical Records; Middle Aged; Thailand; Therapeutic Equivalency; Treatment Outcome

2010
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Scandinavian journal of infectious diseases, 2010, Volume: 42, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Risk Factors

2010
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Greece; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Thienamycins

2010
Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements.
    Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Urban; Humans; Imipenem; Microbial Sensitivity Tests; Patient Transfer; Random Amplified Polymorphic DNA Technique; Spain

2010
Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains.
    American journal of infection control, 2010, Volume: 38, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; Blood; Critical Illness; Cross Infection; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Female; Gastrointestinal Tract; Humans; Imipenem; Male; Middle Aged; Molecular Epidemiology

2010
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
    Yonsei medical journal, 2010, Volume: 51, Issue:6

    Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin

2010
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2010, Nov-18, Volume: 15, Issue:46

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; France; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Microbial Sensitivity Tests

2010
Risk factors for hospital-acquired pneumonia caused by imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Anaesthesia and intensive care, 2010, Volume: 38, Issue:6

    Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors

2010
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Southern medical journal, 2011, Volume: 104, Issue:2

    Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins

2011
Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France.
    The Journal of hospital infection, 2011, Volume: 77, Issue:4

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; France; Hospitals; Humans; Imipenem; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections

2011
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:2

    Topics: Adrenal Cortex Hormones; Aminoglycosides; Anti-Bacterial Agents; Catheters; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Male; Middle Aged; Piperacillin; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome

2011
Comparative activity of carbapenem testing: the COMPACT study.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5

    Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins

2011
Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
    Advances in therapy, 2011, Volume: 28, Issue:4

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Hospitals, Teaching; Humans; Imipenem; Infection Control; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies

2011
Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, District; Humans; Imipenem; Molecular Typing; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan

2011
Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
    Epidemiology and infection, 2012, Volume: 140, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Chi-Square Distribution; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Statistics, Nonparametric; Thienamycins

2012
Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unit.
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Young Adult

2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey

2011
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
    International journal of medical sciences, 2011, Volume: 8, Issue:4

    Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin

2011
Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Intensive Care Units; Intestines; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors

2011
[Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region].
    The Japanese journal of antibiotics, 2011, Volume: 64, Issue:2

    Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Japan; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Urine

2011
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 1

    Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins

2012
Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Young Adult

2012
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:1

    Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea

2012
Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.
    Diagnostic pathology, 2011, Oct-28, Volume: 6

    Topics: beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Hospital Units; Humans; Imipenem; Kidney Transplantation; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia

2011
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:5-6

    Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin

2011
Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Female; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Taiwan

2012
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins

2012
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
    The Journal of surgical research, 2012, Volume: 176, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection

2012
Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Environmental Microbiology; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Intensive Care Units, Pediatric; Male; Republic of Korea; Young Adult

2012
Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Integrons; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction; Sequence Analysis, DNA

2012
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2012
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2013, Volume: 46, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins

2013
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Binding Sites; Carbapenems; Ceftazidime; Cephalosporins; Cross Infection; Gene Expression; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Protein Binding; Protein Isoforms; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Metallo- β - lactamase producing nonfermentative gram-negative bacteria: an increasing clinical threat among hospitalized patients.
    Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:9

    Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disk Diffusion Antimicrobial Tests; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections

2012
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins

2012
Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2013, Volume: 46, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; Cluster Analysis; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan

2013
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins

2012
[Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2012, Volume: 50, Issue:9

    Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2012
Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Female; Humans; Imipenem; Male

2013
Reply: Reducing risk of waterborne imipenem-resistant Acinetobacter baumannii.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Female; Humans; Imipenem; Male

2013
Multidrug-resistant Acinetobacter baumannii infection following para-articular steroid injection in the knee--a case report.
    Bulletin of the NYU hospital for joint diseases, 2012, Volume: 70, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Colistin; Combined Modality Therapy; Cross Infection; Debridement; Drainage; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Injections, Intra-Articular; Knee Joint; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Steroids; Tendinopathy; Treatment Outcome

2012
[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam

2013
Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Catheterization, Central Venous; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Sequence Analysis, DNA; Thienamycins

2002
Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal.
    FEMS microbiology letters, 2002, Sep-24, Volume: 215, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; Cross Infection; Humans; Imipenem; Integrons; Molecular Sequence Data; Portugal

2002
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Child; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Sulbactam

2003
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Dec-28, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis

2000
Nosocomial infectious potency of imipenem-resistant Pseudomonas aeruginosa isolated from obstetric and gynecologic infections.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2003, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2003
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
    La Tunisie medicale, 2003, Volume: 81, Issue:2

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Morocco; Retrospective Studies

2003
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
    Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:7-8

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure

2003
[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Zhonghua yi xue za zhi, 2003, Mar-10, Volume: 83, Issue:5

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests

2003
Imipenem resistance in nonfermenters causing nosocomial urinary tract infections.
    Indian journal of medical sciences, 2003, Volume: 57, Issue:7

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Urinary Tract Infections

2003
Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit.
    Infection control and hospital epidemiology, 2003, Volume: 24, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Hospital Costs; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; New York City; Sentinel Surveillance

2003
An outbreak of conjunctivitis caused by multiresistant Pseudomonas aeruginosa in a Brazilian newborn intensive care unit.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2003, Volume: 7, Issue:4

    Topics: Anti-Bacterial Agents; Brazil; Ciprofloxacin; Conjunctivitis; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Pseudomonas aeruginosa; Pseudomonas Infections

2003
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
    Microbial drug resistance (Larchmont, N.Y.), 2003, Volume: 9 Suppl 1

    Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin; Vancomycin Resistance

2003
Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Logistic Models; Male; Middle Aged; Risk Factors; Thienamycins

2004
Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    The Journal of hospital infection, 2004, Volume: 56, Issue:2

    Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Utilization Review; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Surgical Wound Infection

2004
[Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2004, Volume: 20, Issue:1

    Topics: Antibiosis; Cilastatin; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Risk Factors; Stenotrophomonas maltophilia

2004
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    The Journal of hospital infection, 2004, Volume: 57, Issue:2

    Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Imipenem; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Risk Factors; Thienamycins; Treatment Outcome

2004
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.
    Journal of medical microbiology, 2004, Volume: 53, Issue:Pt 7

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Clavulanic Acid; Cloxacillin; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Genes, Bacterial; Genotype; Imipenem; Isoelectric Focusing; Isoelectric Point; Microbial Sensitivity Tests; Molecular Epidemiology; Sequence Analysis, DNA

2004
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Chromosomes, Bacterial; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Portugal; Reverse Transcriptase Polymerase Chain Reaction; Spain

2004
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins

2004
Outbreak of multidrug resistant Acinetobacter in the neonatal intensive care unit.
    Saudi medical journal, 2004, Volume: 25, Issue:7

    Topics: Acinetobacter Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intubation, Intratracheal; Male; Risk Factors; Saudi Arabia; Survival Rate

2004
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
    Diagnostic microbiology and infectious disease, 2004, Volume: 49, Issue:3

    Topics: Amoxicillin-Potassium Clavulanate Combination; Cross Infection; Drug Interactions; Female; Humans; Imipenem; Male; Melitten; Methicillin Resistance; Microbial Sensitivity Tests; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus aureus

2004
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10

    Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Histocytochemistry; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia; Thienamycins

2004
Metallo-beta-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: continued prevalence of VIM-producing Pseudomonas spp. and increase of IMP-producing Acinetobacter spp.
    Diagnostic microbiology and infectious disease, 2004, Volume: 50, Issue:1

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Humans; Imipenem; Korea; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Population Surveillance; Pseudomonas; Sensitivity and Specificity

2004
An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    The Journal of hospital infection, 2004, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; England; Humans; Imipenem; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2004
Nosocomial bloodstream infections with Burkholderia stabilis.
    The Journal of hospital infection, 2005, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Aged; Bacteremia; Bacterial Typing Techniques; Burkholderia; Burkholderia Infections; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Hospital Mortality; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged; Opportunistic Infections; Random Amplified Polymorphic DNA Technique; Retrospective Studies; Risk Factors; Treatment Outcome; Turkey

2005
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; France; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA

2005
Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    The Journal of hospital infection, 2005, Volume: 59, Issue:2

    Topics: Anti-Bacterial Agents; Brazil; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors

2005
[Analysis of the distribution characteristics and drug sensitivity of infection pathogens in hematology department ward].
    Zhongguo shi yan xue ye xue za zhi, 2004, Volume: 12, Issue:6

    Topics: Cross Infection; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Diseases; Humans; Imipenem; Microbial Sensitivity Tests; Vancomycin

2004
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 2005, Volume: 51, Issue:2

    Topics: Amikacin; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity

2005
Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures.
    Chest, 2005, Volume: 127, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Early Diagnosis; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Population Surveillance; Practice Guidelines as Topic; Prospective Studies; Pseudomonas Infections; Treatment Outcome; Ventilators, Mechanical

2005
Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
    The Journal of hospital infection, 2005, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infection Control; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Turkey

2005
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
    Intensive care medicine, 2005, Volume: 31, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Prognosis; Prospective Studies; Regression Analysis; Respiration, Artificial; Retrospective Studies; Risk Factors; Spain

2005
[Germs that produce the extended spectrum betalactamases].
    La Tunisie medicale, 2004, Volume: 82, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors

2004
Identification of an imipenem-resistant Pseudomonas aeruginosa clone among patients in a hospital in Rio de Janeiro.
    The Journal of hospital infection, 2005, Volume: 60, Issue:1

    Topics: Brazil; Colony Count, Microbial; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Health Services Needs and Demand; Hospitals, Military; Hospitals, University; Humans; Imipenem; Immunodiffusion; Infection Control; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Restriction Mapping; Time Factors

2005
Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:5

    Topics: Acinetobacter baumannii; Base Sequence; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Primers; Drug Resistance, Microbial; Genotype; Humans; Imipenem; Korea; Microbial Sensitivity Tests

2005
Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Infection, 2005, Volume: 33, Issue:3

    Topics: Acinetobacter baumannii; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Risk Factors; Staphylococcus aureus; Stenotrophomonas maltophilia

2005
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Catheterization, Peripheral; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Hypotension; Imipenem; Logistic Models; Male; Risk Factors; Shock; Spain

2005
The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
    Burns : journal of the International Society for Burn Injuries, 2005, Volume: 31, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Burn Units; Burns; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors

2005
Metallo-beta-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 11

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Imipenem; Integrons; Japan; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Providencia; Sequence Analysis, DNA

2005
Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2005,Fall, Volume: 11, Issue:3

    Topics: beta-Lactamases; Ceftazidime; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; France; Hematology; Hospitals; Humans; Imipenem; Integrons; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections

2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Critical care medicine, 2005, Volume: 33, Issue:10

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins

2005
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Catheters, Indwelling; Cross Infection; Disease Transmission, Infectious; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospital Bed Capacity; Hospitals; Humans; Imipenem; Inpatients; Risk Factors; Spain; Surgical Wound Infection

2005
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
    The Journal of infection, 2006, Volume: 53, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Systemic Inflammatory Response Syndrome; Time Factors

2006
Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
    Diagnostic microbiology and infectious disease, 2005, Volume: 53, Issue:3

    Topics: Achromobacter denitrificans; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Imipenem; Integrons; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2005
Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Greece; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins

2006
[Infections caused by Acinetobacter spp. in critically ill ICU patients].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:9

    Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; beta-Lactam Resistance; Child; Comorbidity; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Health Surveys; Hospital Mortality; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prosthesis-Related Infections; Spain; Species Specificity

2005
[A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2005, Volume: 26, Issue:7

    Topics: Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Logistic Models; Male; Middle Aged; Multivariate Analysis; Pseudomonas aeruginosa; Risk Factors

2005
Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gene Order; Humans; Imipenem; Integrons; Plasmids; Polymerase Chain Reaction; Taiwan

2006
Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer, Horizontal; Humans; Imipenem; Integrons; Intensive Care Units; Italy; Meropenem; Morbidity; Pneumonia, Bacterial; Thienamycins

2006
[Drug susceptibility of Pseudomonas aeruginosa strains isolated from patients of a hospital and specialistic outpatients clinics of the SP ZOZ in Nidzica].
    Medycyna doswiadczalna i mikrobiologia, 2005, Volume: 57, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Child; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2005
Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Inpatients; Intensive Care Units; Length of Stay; Microbial Sensitivity Tests; Risk Factors

2006
A clinicomicrobiological study on the importance of pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta1-lactamase production.
    Indian journal of pathology & microbiology, 2006, Volume: 49, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbenicillin; Cross Infection; Hospitals, Teaching; Humans; Imipenem; India; Inpatients; Intensive Care Units; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas; Pseudomonas Infections; Trachea

2006
[Contribution of Pseudomonas Aeruginosa strains to infections in patients of specialistic outpatients clinics of the SP ZOZ in Nidzica].
    Medycyna doswiadczalna i mikrobiologia, 2005, Volume: 57, Issue:4

    Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Child; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Pseudomonas Infections; Species Specificity

2005
Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis

2006
Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
    Intensive care medicine, 2006, Volume: 32, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Imipenem; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Retrospective Studies; Risk Factors

2006
Prospective determination of plasma imipenem concentrations in critically ill children.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7

    Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Infant, Newborn; Infusions, Intravenous; Male

2006
Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.
    Infection control and hospital epidemiology, 2006, Volume: 27, Issue:9

    Topics: Adult; Aged; Case-Control Studies; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Middle Aged; Pennsylvania; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors

2006
Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
    Journal of microbiology (Seoul, Korea), 2006, Volume: 44, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Korea; Phenotype; Polymerase Chain Reaction

2006
[Nosocomial respiratory infection due to an imipenem-resistant Pseudomonas aeruginosa O: 12 strain in a Tunis's neonatal intensive care unit].
    Pathologie-biologie, 2006, Volume: 54, Issue:10

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Pseudomonas aeruginosa; Pseudomonas Infections; Tunisia

2006
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
    Contributions to nephrology, 2007, Volume: 154

    Topics: Anti-Bacterial Agents; Catheters, Indwelling; Cilastatin; Cross Infection; Disinfectants; Drug Therapy, Combination; Humans; Imipenem; Infection Control; Kidney Failure, Chronic; Peritoneal Dialysis; Peritonitis; Pseudomonas Infections; Sodium Hypochlorite

2007
A statistical method for estimating the proportion of cases resulting from cross-transmission of multi-resistant pathogens in an intensive care unit.
    The Journal of hospital infection, 2007, Volume: 65, Issue:2

    Topics: Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infection Control; Intensive Care Units; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Statistics as Topic

2007
[Status of nosocomial urinary tract infections in the ICU: molecular epidemiology of imipenem resistant P. aeruginosa].
    Taehan Kanho Hakhoe chi, 2006, Volume: 36, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Urinary Catheterization; Urinary Tract Infections

2006
Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Chelating Agents; Cross Infection; Drug Resistance, Bacterial; Edetic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet

2007
Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan.
    Microbiology and immunology, 2007, Volume: 51, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Japan; Male; Multigene Family; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections

2007
Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2008, Volume: 12, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Sentinel Surveillance; Turkey

2008
Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; China; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Proteins; Humans; Imipenem; Methyltransferases; Reverse Transcriptase Polymerase Chain Reaction

2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
    The Journal of infection, 2007, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections

2007
High prevalence of metallo-beta-lactamase and 16S rRNA methylase coproduction among imipenem-resistant Pseudomonas aeruginosa isolates in Brazil.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Methyltransferases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction

2007
[Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
    Medycyna doswiadczalna i mikrobiologia, 2007, Volume: 59, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Serratia marcescens; Thienamycins

2007
[Infectivity and resistance to antibiotics of bacterial strains isolated from patients hospitalised in intensive care units].
    Medycyna doswiadczalna i mikrobiologia, 2007, Volume: 59, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchi; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Respiratory Tract Infections; Species Specificity; Virulence

2007
Molecular typing of imipenem-resistant Acinetobacter baumannii-calcoaceticus complex in a Singapore hospital where carbapenem resistance is endemic.
    Infection control and hospital epidemiology, 2007, Volume: 28, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Carbenicillin; Cross Infection; Genotype; Humans; Imipenem; Penicillin Resistance; Phylogeny; Prospective Studies; Singapore

2007
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    The Journal of trauma, 2007, Volume: 63, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome

2007
[The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
    Mikrobiyoloji bulteni, 2007, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin

2007
Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; China; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Molecular Sequence Data; Sequence Analysis, DNA

2007
Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
    Infection, 2007, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Ceftazidime; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Imipenem; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections

2007
An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2007, Volume: 90, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Thailand

2007
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
    Medycyna doswiadczalna i mikrobiologia, 2007, Volume: 59, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies

2007
Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Europe; Genetic Variation; Geography; Humans; Imipenem; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique

2008
Susceptibility of bacterial isolates from Turkey--a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:6

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins; Turkey

2007
Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.
    Infection control and hospital epidemiology, 2008, Volume: 29, Issue:4

    Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Genetic Variation; Germany; Humans; Imipenem; Intensive Care Units; Prospective Studies; Pseudomonas aeruginosa; Sentinel Surveillance

2008
Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Blotting, Western; Case-Control Studies; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Porins; Pseudomonas aeruginosa; Pseudomonas Infections

2008
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:11-12

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins

2006
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline

2008
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Greece; Hospitals, General; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Sentinel Surveillance; Sequence Analysis, DNA

2008
Controlling the clonal spread of Pseudomonas aeruginosa infection.
    Infection control and hospital epidemiology, 2008, Volume: 29, Issue:6

    Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Infection Control; Length of Stay; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors

2008
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
    European journal of clinical microbiology, 1982, Volume: 1, Issue:1

    Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins

1982
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis

1982
Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem.
    The Journal of hospital infection, 1995, Volume: 31, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Burns; Cross Infection; Disease Outbreaks; Humans; Imipenem; Infection Control; Microbial Sensitivity Tests; Thienamycins

1995
Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:5

    Topics: beta-Lactam Resistance; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1995
Comparative in vitro killing activity of meropenem versus imipenem against multiresistant nosocomial Pseudomonas aeruginosa.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7, Issue:3

    Topics: Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Imipenem; In Vitro Techniques; Meropenem; Pseudomonas Infections; Thienamycins; Time Factors

1995
An outbreak of Enterobacter cloacae associated with contamination of a blood gas machine.
    The Journal of infection, 1995, Volume: 30, Issue:3

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Gas Analysis; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Thienamycins

1995
Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.
    Neurosurgery, 1994, Volume: 35, Issue:5

    Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Brain Diseases; Brain Neoplasms; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Surgical Wound Infection

1994
Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods.
    Journal of clinical microbiology, 1994, Volume: 32, Issue:11

    Topics: Acinetobacter; Bacterial Typing Techniques; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Imipenem; Phenotype

1994
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
    Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:1

    Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests

1994
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.
    Lancet (London, England), 1994, Nov-12, Volume: 344, Issue:8933

    Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Cross Infection; Disease Outbreaks; DNA, Bacterial; Environmental Microbiology; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; New York; Polymyxin B; Sulbactam

1994
Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:6

    Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans; Imipenem; Male

1993
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests

1993
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 91

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence

1993
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
    Journal of clinical microbiology, 1993, Volume: 31, Issue:1

    Topics: Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; beta-Lactamases; Cephalosporinase; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids

1993
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
    The Journal of infectious diseases, 1993, Volume: 167, Issue:2

    Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam

1993
Transferable resistance to imipenem in hospital isolates of Pseudomonas aeruginosa.
    Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:1

    Topics: Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Species Specificity; Time Factors

1993
Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:2

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Penicillins; Thienamycins

1995
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period.
    The Journal of hospital infection, 1997, Volume: 35, Issue:3

    Topics: Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Pseudomonas Infections; Retrospective Studies; Thienamycins

1997
Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2

    Topics: Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

1997
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:2

    Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Intensive Care Units; Outpatients; Pseudomonas aeruginosa; Vancomycin

1997
Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:6

    Topics: Anti-Bacterial Agents; Ceftazidime; Cohort Studies; Cross Infection; Female; Humans; Imipenem; Male; Middle Aged; Xanthomonas

1997
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
    American journal of infection control, 1997, Volume: 25, Issue:5

    Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin

1997
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
    American journal of perinatology, 1998, Volume: 15, Issue:1

    Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins

1998
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries

1997
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1998, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin

1998
Imipenem resistance in aerobic gram-negative bacteria.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:2

    Topics: beta-Lactam Resistance; Burn Units; Burns; Cross Infection; Gram-Negative Aerobic Bacteria; Humans; Imipenem; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Thienamycins

1998
Transduction of antibiotic resistance including imipenem resistance by wild type phages from nosocomial strains of Pseudomonas aeruginosa.
    Acta virologica, 1997, Volume: 41, Issue:5

    Topics: Anti-Bacterial Agents; Carbenicillin; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Phages; Thienamycins; Transduction, Genetic

1997
[Imipenem resistance in Pseudomonas aeruginosa].
    Wiener klinische Wochenschrift, 1998, Oct-30, Volume: 110, Issue:20

    Topics: Austria; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Polymorphism, Restriction Fragment Length; Pseudomonas Infections; Thienamycins

1998
[Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
    Medycyna doswiadczalna i mikrobiologia, 1998, Volume: 50, Issue:1-2

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Species Specificity; Thienamycins; Ticarcillin

1998
Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:10

    Topics: Adult; Aged; beta-Lactam Resistance; Ceftazidime; Cephalosporins; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Thienamycins

1998
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin

1998
Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients.
    The Journal of hospital infection, 1999, Volume: 42, Issue:1

    Topics: Boston; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Intensive Care Units; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Serratia Infections; Serratia marcescens; Thienamycins

1999
[Imipenem. Evaluation of its role in antibacterial therapy of severe hospital infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1999, Volume: 44, Issue:5

    Topics: Cross Infection; Dose-Response Relationship, Drug; Economics, Pharmaceutical; Humans; Imipenem; Microbial Sensitivity Tests; Thienamycins

1999
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris

1999
Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
    JPMA. The Journal of the Pakistan Medical Association, 1999, Volume: 49, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Thienamycins

1999
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:1

    Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin

2000
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:9

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins

2000
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin

2000
An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.
    Infection control and hospital epidemiology, 2001, Volume: 22, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Risk Factors

2001
PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:12

    Topics: Acinetobacter; Acinetobacter Infections; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Meropenem; Polymerase Chain Reaction; Polymorphism, Genetic; Spain; Thienamycins

2000
Case-control study of risk factors for the development of enterococcal bacteremia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:2

    Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins

2001
[Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Chile; Cross Infection; Humans; Imipenem; Meropenem; Thienamycins

2000
Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor.
    Infection control and hospital epidemiology, 2001, Volume: 22, Issue:7

    Topics: Bronchoscopes; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Equipment Contamination; Female; Hospitals, Teaching; Humans; Imipenem; Male; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins

2001
Clonal spread of imipenem-resistant Pseudomonas aeruginosa in the intensive care unit of a Turkish hospital.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Clone Cells; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance; Female; Humans; Imipenem; Infant; Intensive Care Units; Length of Stay; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Turkey

2001
Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2002, Volume: 6, Issue:1

    Topics: Bacterial Typing Techniques; Brazil; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Diseases; Restriction Mapping; Thienamycins

2002
Efficacy of teicoplanin and imipenem on respiratory infections in high risk patients.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3 Suppl 1

    Topics: Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas Infections; Risk Factors; Staphylococcal Infections; Teicoplanin; Thienamycins

1991
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
    Minerva chirurgica, 1992, Oct-31, Volume: 47, Issue:20

    Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors

1992
Resistance to imipenem among selected gram-negative bacilli in the United States.
    Infection control and hospital epidemiology, 1992, Volume: 13, Issue:1

    Topics: Ceftazidime; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Logistic Models; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States

1992
[Methicillin resistant Staphylococcus aureus].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Mar-10, Volume: 81, Issue:3

    Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992
Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumoniae nosocomial meningitis.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:2

    Topics: Aged; Cross Infection; Humans; Imipenem; Klebsiella Infections; Male; Meningitis, Bacterial

1991
Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
    Contributions to nephrology, 1991, Volume: 93

    Topics: Acute Kidney Injury; Adult; Aged; Bacterial Infections; Cilastatin; Cross Infection; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Imipenem; Male; Metabolic Clearance Rate; Middle Aged

1991
[Resistance of hospital flora to imipenem. Experience in two intensive care units].
    Presse medicale (Paris, France : 1983), 1991, Oct-19, Volume: 20, Issue:33

    Topics: Acinetobacter; Cross Infection; Drug Resistance, Microbial; Escherichia coli; France; Humans; Imipenem; In Vitro Techniques; Intensive Care Units; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens

1991
[Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
    Pathologie-biologie, 1991, Volume: 39, Issue:2

    Topics: Cefsulodin; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin

1991
Changes in clinically separated strains of glucose non-fermented gram-negative bacilli following the induction of imipenem/cilastatin.
    Journal of internal medicine, 1991, Volume: 229, Issue:6

    Topics: Bacterial Infections; Cilastatin; Cross Infection; Fermentation; Glucose; Gram-Negative Bacteria; Humans; Imipenem; Retrospective Studies

1991
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990, Volume: 9, Issue:4

    Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin

1990
[In vitro activity of imipenem against hospital bacteria].
    Presse medicale (Paris, France : 1983), 1990, Apr-04, Volume: 19, Issue:13

    Topics: Acinetobacter; Bacteria, Anaerobic; Cross Infection; Dose-Response Relationship, Drug; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; In Vitro Techniques; Pseudomonas

1990
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Dec-10, Volume: 79, Issue:12

    Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

1990
Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors.
    Infection control and hospital epidemiology, 1990, Volume: 11, Issue:3

    Topics: Bacterial Infections; Case-Control Studies; Cross Infection; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas

1990
Transductional analysis of imipenem-ceftazidime-and azactam resistant Pseudomonas aeruginosa strains from nosocomial infections.
    Journal of hygiene, epidemiology, microbiology, and immunology, 1989, Volume: 33, Issue:2

    Topics: Aztreonam; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Humans; Hydrolysis; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Transduction, Genetic

1989
[In vitro effect of antibiotics against hospital strains of Acinetobacter baumanii].
    Pathologie-biologie, 1989, Volume: 37, Issue:5 Pt 2

    Topics: Acinetobacter; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Ticarcillin

1989
[Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Immunitat und Infektion, 1986, Volume: 14, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1986
In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Humans; Imipenem; Microbial Sensitivity Tests; Oxacillin; Pseudomonas aeruginosa; Serratia; Staphylococcus; Thienamycins

1987
Imipenem/cilastatin in the treatment of severe hospital infections.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:2

    Topics: Adult; Aged; Amikacin; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins

1988
Imipenem/cilastatin in the treatment of severe nosocomial pneumonia.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1988, Oct-15, Volume: 74, Issue:8

    Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Dipeptidases; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia

1988
Imipenem-cilastatin. A new dimension.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1988, Nov-05, Volume: 74, Issue:9 Suppl

    Topics: Adolescent; Adult; Aged; Cilastatin; Cross Infection; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia

1988
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:4

    Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins

1986
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:1

    Topics: Amoxicillin; Bacteria, Anaerobic; Clavulanic Acid; Clavulanic Acids; Cross Infection; Hospitals, Community; Humans; Imipenem; Microbial Sensitivity Tests; Thienamycins

1986
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
    Postgraduate medicine, 1987, Volume: 81, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin

1987
Experience with imipenem/cilastatin in the intensive care unit.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Adolescent; Adult; Aged; Cilastatin; Critical Care; Cross Infection; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Thienamycins

1986
Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Adult; Aged; Bacteria; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins

1986
In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Anti-Bacterial Agents; Bacteria; Cross Infection; Humans; Imipenem; Microbial Sensitivity Tests; Portugal; Thienamycins

1986
Clinical outcome of nosocomial pneumonia following imipenem/cilastatin therapy.
    Drug intelligence & clinical pharmacy, 1987, Volume: 21, Issue:3

    Topics: Adult; Cilastatin; Cross Infection; Cyclopropanes; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Thienamycins

1987
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
    Journal of the Royal Army Medical Corps, 1987, Volume: 133, Issue:3

    Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection

1987
Imipenem/cilastatin: monotherapy of hospital infections.
    Scandinavian journal of infectious diseases. Supplementum, 1987, Volume: 52

    Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Humans; Imipenem; Thienamycins

1987
[Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus].
    Pathologie-biologie, 1986, Volume: 34, Issue:5 Pt 2

    Topics: Acinetobacter; Acinetobacter Infections; Cefotaxime; Ceftazidime; Ceftizoxime; Cross Infection; Humans; Imipenem; Thienamycins

1986
[Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
    Infection, 1986, Volume: 14 Suppl 2

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Thienamycins

1986
Pneumonia treated with imipenem/cilastatin.
    The American journal of medicine, 1985, Jun-07, Volume: 78, Issue:6A

    Topics: Adult; Aged; Bacteria; Bacterial Infections; Cilastatin; Cross Infection; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia; Pseudomonas Infections; Thienamycins

1985